Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Soberlink Healthcare LLC | INDUSTRY |
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.
The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and who are enrolled in Aware Recovery Care's In-Home Addiction Treatment program where Care Teams will monitor cloud-based breathalyzer results. Soberlink's cloud-based breathalyzer system will provide data to Care Team if the Client has relapsed or is not compliant with testing through the Soberlink System. Clients will use Soberlink for 180 days within context of routine alcohol use disorder treatment at Aware Recovery Care.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Primary diagnosis alcohol use disorder (AUD) | Primary diagnosis of alcohol use disorder (AUD) population enrolled in In-Home Addiction Treatment Program. |
| |
| Secondary diagnosis alcohol use disorder (AUD) | Secondary diagnosis of alcohol use disorder (AUD) population enrolled in In-Home Addiction Treatment Program. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Soberlink | Device | Soberlink delivers real-time blood alcohol results to people who support individuals in recovery from alcohol use disorder. In-Home Addiction Treatment program Care Team monitors and responds to results as part of care to improve treatment outcomes. |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of Retention in Treatment | Participation in In-Home Addiction Treatment program using length of stay reports. | 180 days duration of subject participation |
| Brief Addiction Monitor questionnaire | Measure change in client report of symptoms related to alcohol use disorder | Conducted monthly throughout 180 days duration of subject participation |
| Positive Outcomes Measures Survey | Measures changes in quality of life using client self-report inquiring about employment, connection to care team, community engagement using yes/no answer key | Completed at week 3 or 4 and Week 20 during 180 days duration of subject participation |
| Client Survey Related to use of Soberlink | Measures self-report of quality of life and experience with device using 5-point Likert scale (minimum Strongly Disagree, maximum Strongly Agree) | Completed at end of 180 days duration of subject participation |
| Measure | Description | Time Frame |
|---|---|---|
| Relapse Rates | Occurrence of alcohol use | Measured throughout 180 days duration of subject participation |
| Compliance with Testing | Occurrence of Missed Tests |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Subjects are active participants in Aware Recovery Care, an In-Home Addiction Treatment program with an active primary or secondary diagnosis of alcohol use disorder.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Courtney MacNeill, LMSW | Research Associate | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aware Recovery Care | North Haven | Connecticut | 06473 | United States | ||
| Aware Recovery Care |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000437 | Alcoholism |
| ID | Term |
|---|---|
| D019973 | Alcohol-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
| Measured throughout 180 days duration of subject participation |
| Hospitalization | Occurrence of Emergency Room and Inpatient hospital admissions | Measured throughout 180 days duration of subject participation |
| Detox and Residential Admissions | Occurrence of residential treatment and detox admissions | Measured throughout 180 days duration of subject participation |
| Bedford |
| New Hampshire |
| 03111 |
| United States |